Market revenue in 2023 | USD 1,882.0 million |
Market revenue in 2030 | USD 2,942.2 million |
Growth rate | 6.6% (CAGR from 2023 to 2030) |
Largest segment | Transdermal patches |
Fastest growing segment | Infusion Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Photodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters |
Key market players worldwide | Abbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.
Transdermal patches was the largest segment with a revenue share of 23.08% in 2023. Horizon Databook has segmented the Brazil drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil stands out among other Latin American countries due to its substantial potential for growth, driven by a large population and a notable increase in the number of surgical procedures. According to the ISAPS global survey 2022, Brazil ranks as the second-largest country worldwide for surgical procedures, accounting for 8.9% of the global count, following the U.S. at 22%.
In addition, according to the Serviços e Informações do Brasil, over 12,000 organ transplants were performed between January 2021 and November 2021. This significant number of surgeries highlights the robustness of Brazil's healthcare system and the growing demand for medical devices, including drug-device combination products.
Brazil has a considerable prevalence of chronic health conditions, notably respiratory & cardiovascular diseases. These prevailing health issues increase the necessity for effective surgical treatments, boosting the demand for advanced drug-device combination products. As Brazil witnesses a rise in the number of surgical procedures and addresses the challenges posed by chronic illnesses, the market for these innovative medical solutions is anticipated to grow during the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil drug device combination products market , including forecasts for subscribers. This country databook contains high-level insights into Brazil drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account